Rapid influenza diagnostic tests (RIDTs) are a type of rapid diagnostic test that can detect influenza virus infection in a patient within 15 minutes. RIDTs are used to diagnose patients with suspected influenza and to identify the type of virus causing the infection. The global RIDT market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021-2030, due to increasing incidence rates of seasonal and pandemic flu, increasing demand for point-of-care testing devices, and growing awareness about RIDTs among healthcare professionals.
The global RIDT market is segmented by type into digital RIDs and conventional RIDs; by application into hospitals & clinics and laboratories; and by region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The digital segment accounted for more than 50% share in 2018 owing to its high accuracy rate as compared with conventional tests. Hospitals & clinics accounted for more than 50% share in 2018 owing to their higher adoption rate as compared with laboratories due to their ease of use. North America was the largest regional market in 2018 owing to its high adoption rate among hospitals & clinics as well as laboratories due to its stringent regulatory environment which mandates use of rapid diagnostic tests for all patients suspected with flu or other respiratory infections.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of influenza in the world.
- Increasing number of people suffering from chronic diseases such as diabetes, asthma, and heart disease.
- Increasing number of people travelling to different countries for business or leisure purposes which increases the risk of contracting influenza virus and spreading it to other parts of the world.
- Increase in awareness about RIDT among healthcare professionals and patients due to its accuracy in diagnosing influenza virus infection compared with other diagnostic tests available on the market today such as ELISA test which is not accurate enough for diagnosis because it can also detect antibodies against other viruses like dengue fever, yellow fever, measles etc, PCR test which is expensive and time-consuming, culture test which takes a long time to produce results and requires skilled personnel for handling samples etc, immunofluorescence assay (IFA) test which is not sensitive enough for diagnosis because it can only detect antibodies against one type of influenza virus at a time while there are many types circulating in different parts of the world at any given point in time etc, rapid antigen detection tests (RADTs) that require skilled personnel for handling samples etc, serology tests that require skilled personnel for handling samples etc, throat swabs that require skilled personnel for handling samples etc, viral culture that requires skilled personnel for handling samples etc;.
- Availability of RIDT kits on online stores like Amazon or eBay at affordable prices.
Industry Growth Insights published a new data on “Rapid Influenza Diagnostic Test (RIDT) Market”. The research report is titled “Rapid Influenza Diagnostic Test (RIDT) Market research by Types (Digital RIDTs, Conventional RIDT), By Applications (Hospitals & Clinics, Laboratories, Other), By Players/Companies Thermo Fisher Scientific, Roche Diagnostics, Abbott, Quidel Corporation, Becton, Dickinson and Company, DiaSorin, SA Scientific Ltd., Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser AG), Luminex Corporation”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Influenza Diagnostic Test (RIDT) Market Research Report
By Type
Digital RIDTs, Conventional RIDT
By Application
Hospitals & Clinics, Laboratories, Other
By Companies
Thermo Fisher Scientific, Roche Diagnostics, Abbott, Quidel Corporation, Becton, Dickinson and Company, DiaSorin, SA Scientific Ltd., Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser AG), Luminex Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global Rapid Influenza Diagnostic Test (RIDT) Market Report Segments:
The global Rapid Influenza Diagnostic Test (RIDT) market is segmented on the basis of:
Types
Digital RIDTs, Conventional RIDT
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Roche Diagnostics
- Abbott
- Quidel Corporation
- Becton
- Dickinson and Company
- DiaSorin
- SA Scientific Ltd.
- Meridian Bioscience, Inc.
- Analytik Jena AG (Endress+Hauser AG)
- Luminex Corporation
 Market Overview.svg)
Highlights of The Rapid Influenza Diagnostic Test (RIDT) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Digital RIDTs
- Conventional RIDT
- By Application:
- Hospitals & Clinics
- Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Influenza Diagnostic Test (RIDT) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid Influenza Diagnostic Test (RIDT) is a rapid test for the detection of influenza A and B viruses in respiratory secretions.
Some of the key players operating in the rapid influenza diagnostic test (ridt) market are Thermo Fisher Scientific, Roche Diagnostics, Abbott, Quidel Corporation, Becton, Dickinson and Company, DiaSorin, SA Scientific Ltd., Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser AG), Luminex Corporation.
The rapid influenza diagnostic test (ridt) market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rapid Influenza Diagnostic Test (RIDT) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rapid Influenza Diagnostic Test (RIDT) Market - Supply Chain
4.5. Global Rapid Influenza Diagnostic Test (RIDT) Market Forecast
4.5.1. Rapid Influenza Diagnostic Test (RIDT) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rapid Influenza Diagnostic Test (RIDT) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rapid Influenza Diagnostic Test (RIDT) Market Absolute $ Opportunity
5. Global Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
5.3.1. Digital RIDTs
5.3.2. Conventional RIDT
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
6.3.1. Hospitals & Clinics
6.3.2. Laboratories
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rapid Influenza Diagnostic Test (RIDT) Demand Share Forecast, 2019-2026
9. North America Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
9.4.1. Hospitals & Clinics
9.4.2. Laboratories
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
9.7.1. Digital RIDTs
9.7.2. Conventional RIDT
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rapid Influenza Diagnostic Test (RIDT) Demand Share Forecast, 2019-2026
10. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
10.4.1. Hospitals & Clinics
10.4.2. Laboratories
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
10.7.1. Digital RIDTs
10.7.2. Conventional RIDT
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rapid Influenza Diagnostic Test (RIDT) Demand Share Forecast, 2019-2026
11. Europe Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
11.4.1. Hospitals & Clinics
11.4.2. Laboratories
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
11.7.1. Digital RIDTs
11.7.2. Conventional RIDT
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rapid Influenza Diagnostic Test (RIDT) Demand Share, 2019-2026
12. Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
12.4.1. Hospitals & Clinics
12.4.2. Laboratories
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
12.7.1. Digital RIDTs
12.7.2. Conventional RIDT
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rapid Influenza Diagnostic Test (RIDT) Demand Share, 2019-2026
13. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Application
13.4.1. Hospitals & Clinics
13.4.2. Laboratories
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Market Size and Volume Forecast by Type
13.7.1. Digital RIDTs
13.7.2. Conventional RIDT
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rapid Influenza Diagnostic Test (RIDT) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rapid Influenza Diagnostic Test (RIDT) Market: Market Share Analysis
14.2. Rapid Influenza Diagnostic Test (RIDT) Distributors and Customers
14.3. Rapid Influenza Diagnostic Test (RIDT) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Roche Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Quidel Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dickinson and Company
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DiaSorin
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SA Scientific Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Meridian Bioscience, Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Analytik Jena AG (Endress+Hauser AG)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Luminex Corporation
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
